Alphamab Oncology ( ($HK:9966) ) has provided an update. Alphamab Oncology announced that its drug JSKN003 has received Fast Track Designation ...
The US FDA has granted fast track designation to the novel amanitin-based antibody-drug conjugate (ADC) pamlectabart ...
The approach, published on 23 October in Science, builds on a trend that is sweeping the field of drug discovery: the use of ...
Five people were killed in the attacks as the military targeted suspected trafficking in an area where large amounts of ...
US anti-drug assistance to Colombia is fundamental and it will benefit no one to cut resources used to fight the cocaine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback